ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 117 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,988 | -44.1% | 2,069,293 | +0.3% | 0.11% | -40.9% |
| Q2 2023 | $19,657 | -6.2% | 2,062,683 | +8.3% | 0.19% | -8.4% |
| Q1 2023 | $20,952 | -8.8% | 1,904,722 | +22.7% | 0.20% | -12.9% |
| Q4 2022 | $22,970 | -99.9% | 1,552,014 | +70.8% | 0.23% | +21.4% |
| Q3 2022 | $17,369,000 | +20.5% | 908,913 | +34.3% | 0.19% | +23.1% |
| Q2 2022 | $14,420,000 | +252.3% | 676,678 | +218.4% | 0.16% | +333.3% |
| Q1 2022 | $4,093,000 | – | 212,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,684,232 | $46,113,272 | 3.06% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,105,309 | $5,869,191 | 2.34% |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $15,930,000 | 1.78% |
| Sio Capital Management, LLC | 635,969 | $3,376,995 | 1.04% |
| Rubric Capital Management LP | 5,034,530 | $26,733,354 | 1.00% |
| Tejara Capital Ltd | 309,179 | $1,641,740 | 0.93% |
| AlphaCentric Advisors LLC | 165,000 | $876,150 | 0.50% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,135,227 | $6,028,055 | 0.33% |
| Orbimed Advisors | 1,914,479 | $10,165,883 | 0.22% |
| Two Seas Capital LP | 164,807 | $875,125 | 0.18% |